口袋女优

Katherine Kahn

Katherine Kahn

Authors >

Katherine Kahn

Kate is a staff writer at 口袋女优, covering the infectious diseases beat. She brings over fifteen years of corporate and freelance experience in writing for physician and consumer audiences. Kate holds a BA in English Literature from Wilson College, a DVM from Tufts University Cummings School of Veterinary Medicine, and a master鈥檚-level diploma from the New England School of Acupuncture. Before becoming a writer, Kate had clinical practice as a veterinarian and acupuncturist. Her creative writing has won her scholarships and residencies to the Hedgebrook Foundation, Ragdale Foundation, and the Montana Artists鈥� Refuge.

Connect:

email image

Latest from Katherine Kahn

A photo of a mature man in a hospital room.

CDC: U.S. Falls Short in Improving QoL for Older People With HIV

Addressing shortcomings will require moving "beyond clinical care," agency says

A photo of a box of vials of the modified vaccinia Ankara-Bavarian Nordic (MVA-BN; Jynneos) mpox vaccine.

Single Dose of Mpox Vaccine Series Appears to Give Partial Protection

However, full two-dose vaccine series likely needed to curtail mpox resurgence, researchers say

A photo of a pharmacist holding a box of molnupiravir (Lagevrio) capsules.

Molnupiravir May Offer Modest 6-Month Benefits for High-Risk COVID Patients

Secondary analysis of trial data consistent with observational studies

FDA ADCOMM sulopenem etzadroxil/probenecid (sulopenem) over a computer rendering of bacteria spilling from a bladder.

FDA Advisors Question Potential Role of Novel Oral UTI Antibiotic

Concerns about patient selection, antibiotic resistance dominated the discussion

FDA ADCOMM sulopenem etzadroxil/probenecid (sulopenem) over a computer rendering of bacteria spilling from a bladder.

FDA Reviewers Voice Concerns Over Novel UTI Treatment

Oral antibiotic has potential for inappropriate use, agency says

A photo of a boy receiving treatment for mpox at a hospital in Goma, eastern Democratic Republic of the Congo.

Mpox Is Back in the News. Here's What Clinicians Need to Know.

This new surge is different, WHO leader says

FDA EUA Novavax COVID-19 vaccine over a photo of a vial of Nuvaxovid and a syringe.

FDA OKs Updated Novavax COVID Shot

Unlike the mRNA vaccines, protein-based vaccine targets JN.1 strain

A computer rendering of an Mpox virus particle.

Amid Global Emergency, FDA OKs Another Vaccine for Mpox

"All effective tools" are needed to combat mpox threat, expert says

A computer rendering of Mycobacterium tuberculosis bacteria.

Amino Acid Derivative Fails to Eliminate TB Infection in Mid-Stage Trial

However, N-acetylcysteine may improve lung function, small study suggests

An electron micrograph of Clostridioides difficile bacteria

Another Injectable Toxoid Vaccine Flops for C. Diff

It's time to look at oral vaccines to prevent C. difficile infections, experts say

1

鈥�